In our previous blog post opening this year’s Global Asbestos Awareness Week, we mentioned that prevention of mesothelioma can take several different shapes. Avoiding exposures to asbestos is one such method. However, while theoretically valid, in reality this method falls short in accomplishing this goal because asbestos is showing no signs of going away. It […]
The Meso Foundation released a statement from its executive director, Mary Hesdorffer, APRN, about AstraZeneca’s tremelimumab trial for mesothelioma.
In an AstraZeneca press release issued yesterday, the company states that “DETERMINE, the Phase IIb clinical trial of 10 mg/kg tremelimumab monotherapy in second or third-line treatment of unresectable malignant mesothelioma, did not meet its primary endpoint […]
In the first of a special two-part series of Meet the Mesothelioma Experts, we interview our 2015 mesothelioma research grant recipients. In this session, we interview grant recipients Dr. Andrea McClatchey of the Massachusetts General Hospital in Boston, Dr. Sean Carlin of Memorial Sloan Kettering Cancer Center in New York, and Dr. Jill Ohar of […]
We are pleased to announce the funding of five new mesothelioma research projects by the Meso Foundation. To date the Meso Foundation has funded 99 projects amounting to over $9.4 million awarded toward mesothelioma research.
The Meso Foundation’s research program follows a rigorous peer-review system modeled after that of the National Institutes of Health. Each year, […]
In the latest iteration of its budget bill, Congress included $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP). The bill will be voted on in the House on Friday, and in the Senate shortly thereafter.
If the bill does pass, this level of funding will be consistent with funding for […]